Simran Farms Limited has announced its unaudited financial results for the quarter and nine months ended December 31, 2025, alongside significant board changes during a meeting held on February 14, 2026. The company, primarily engaged in poultry breeding and farming activities, reported mixed financial performance with notable improvements in quarterly results.

Financial Performance Overview

The company's standalone financial results show a significant improvement in quarterly performance. For Q3 FY26, Simran Farms reported a net profit of ₹109.42 lakhs compared to ₹12.89 lakhs in the corresponding quarter of the previous year, representing a substantial increase. However, the nine-month performance shows a decline, with net profit at ₹215.30 lakhs compared to ₹904.48 lakhs in the previous year.

Consolidated Results

The consolidated financial results, which include subsidiary Puregene Biotech Limited, show similar trends. Consolidated net profit for Q3 FY26 stood at ₹114.18 lakhs compared to ₹14.09 lakhs in the previous year's quarter. For the nine-month period, consolidated net profit was ₹225.74 lakhs against ₹910.53 lakhs in the corresponding period of the previous year.

Board Changes and New Director Appointment

The board approved significant changes in its composition with Mrs. Sherry Mac (DIN: 10736916) resigning from her position as Non-Executive Woman Independent Director with effect from the close of business hours on February 14, 2026. Based on the recommendation of the Nomination and Remuneration Committee, the board appointed Adv. Deepika Sharma (DIN: 11543076) as Additional Director under the category of Non-Executive Woman Independent Director for a five-year term from February 14, 2026, to February 13, 2031, subject to shareholder approval.

Committee Reconstitution

Following the board changes, all statutory committees have been reconstituted with the new director. The company has confirmed that Adv. Deepika Sharma has not been debarred from holding the office of Director by virtue of any SEBI order or any other authority.

Operational Highlights

The company's revenue from operations increased to ₹23,323.25 lakhs in Q3 FY26 from ₹18,909.03 lakhs in the corresponding quarter of the previous year. Total expenses for the quarter were ₹23,168.36 lakhs, with raw material consumption being the major component at ₹19,595.92 lakhs. The company maintained its focus on poultry breeding and farming activities, with no identifiable operating segments requiring separate disclosure under IND AS-108.

Corporate Compliance

The financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors. The results have been reviewed by statutory auditors Khandelwal Kakani & Company in accordance with Regulation 33 of the SEBI Listing Regulations. The company confirmed that all necessary due diligence was exercised to ensure the financial results provide a true and fair view of its affairs. The board meeting commenced at 4:15 PM and concluded at 6:45 PM on February 14, 2026.

Simran Farms Limited has scheduled a board meeting for February 14, 2026, to consider and approve its financial results for the third quarter of fiscal year 2026. The company filed the intimation with BSE Limited on February 7, 2026, in compliance with regulatory requirements.

Board Meeting Details

The Board of Directors meeting (Serial No. 04/2025-26) will be held at the company's registered office located at 1-B, Vikas Rekha Complex, Khatiwala Tank, Indore, Madhya Pradesh. The meeting has been convened under Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Agenda Items

The board will deliberate on specific financial matters during the scheduled meeting. The primary agenda includes consideration and approval of both standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2025, along with the limited review report. Additionally, other routine business matters will be discussed with the permission of the chair.

Trading Window Guidelines

In continuation of the company's earlier disclosure dated December 26, 2025, Simran Farms has provided updated information regarding trading restrictions. The trading window for dealing in company securities will reopen 48 hours after the declaration of financial results for all designated persons, their immediate relatives, and connected persons covered under the company's insider trading code.

Regulatory Compliance

The company has submitted the required information in both XBRL mode using the exchange-provided excel template and PDF format within the prescribed time limits. This filing ensures compliance with stock exchange requirements and provides transparency to stakeholders regarding the upcoming financial disclosure.

Simran Farms Limited, with BSE Scrip Code 519566 and ISIN No. INE354D01017, continues to maintain its regulatory obligations while keeping investors informed about significant corporate developments through proper disclosure mechanisms.